245743-64-0

Basic information

• Product Name: methyl 5-chloro-2-fluoro-4-hydroxybenzoate
• Synonyms: methyl 5-chloro-2-fluoro-4-hydroxybenzoate
• CAS NO: 245743-64-0
• Molecular Formula: C₈H₆ClFO₃
• Molecular Weight: 204.5828432
• EINECS: -0
• Mol File: 245743-64-0.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: methyl 5-chloro-2-fluoro-4-hydroxybenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 5-chloro-2-fluoro-4-hydroxybenzoate(245743-64-0)
• EPA Substance Registry System: methyl 5-chloro-2-fluoro-4-hydroxybenzoate(245743-64-0)

Safety Data

• Hazardous Substances Data: 245743-64-0(Hazardous Substances Data)

Usage

General Description

Methyl 5-chloro-2-fluoro-4-hydroxybenzoate is a chemical compound with the molecular formula C8H6ClFO3. It is a derivative of benzoic acid and belongs to the class of organic compounds known as salicylic acid and derivatives. methyl 5-chloro-2-fluoro-4-hydroxybenzoate is commonly used in the production of pharmaceuticals and industrial chemicals. It has antimicrobial and anti-inflammatory properties, making it useful in various medicinal applications. Additionally, it has been reported to have potential for use as a pesticide and a fungicide due to its ability to inhibit the growth of microorganisms.

Upstream product

• 211172-73-5 methyl 5-chloro-2-fluoro-4-methoxybenzoate 
• 204254-70-6 5-amino-4-methoxy-2-nitro-benzoic acid 
• 130017-52-6 5-acetylamino-4-methoxy-2-nitrobenzoic acid 
• 79025-26-6 methyl 2-amino-5-chloro-4-methoxybenzoate 
• 74127-07-4 5-chloro-4-methoxy-2-nitrobenzoic acid 
• 245743-63-9 methyl 5-chloro-4-methoxy-2-nitrobenzoate 
• 211172-72-4 5-chloro-2-fluoro-4-methoxybenzoic acid 
• 65145-13-3 2-fluoro-4-hydroxybenzoic acid 
• 67-56-1 methanol 
• 593280-19-4 5-chloro-2-fluoro-4-hydroxy-benzoic acid 
• 197507-22-5 methyl 2-fluoro-4-hydroxybenzoate 

Downstream Products

• 211172-74-6 (R)-5-chloro-2-fluoro-4-(2-octyloxy)benzoate 

Relevant articles and documents

NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROSIS

The present invention discloses compounds according to Formula (I) Wherein R1, R2, L, A1, A2, A3, Cy and the subscript n are as defined herein. The present invention relates to antagonists compounds of sphingosine 1-phosphate (SIP) receptor, methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, for the prophylaxis and/or treatment of diseases involving fibrotic diseases, inflammatory diseases, respiratory diseases, autoimmune diseases, metabolic diseases, cardiovascular diseases, and/or proliferative diseases by administering the compound of the invention.

Compounds and methods for doping liquid crystal hosts

This invention provides chiral thioindigo compounds for doping smectic liquid crystal hosts, wherein the compounds modulate a chiral bulk property of an induced chiral smectic liquid crystal phase upon irradiation at a wavelength in the visible range. Modulation of the chiral bulk property is effected by reversible trans-cis photoisomerization of the compound upon irradiation. The compounds maintain their rod-like shape in both isomeric forms, and hence do not destabilize the chiral smectic liquid crystal phase. Compounds according to the invention are useful in optical devices such as optical switches, displays, and memory.